TB-RICC 3.0

Document text

Principal Investigator: BRUNO DE BEZERRIL ANDRADE
Organization: RUTGERS BIOMEDICAL AND HEALTH SCIENCES
Fiscal Year: 2024
Award: $3,960,184
Funding agency: National Institute of Allergy and Infectious Diseases

TB-RICC 3.0 is designed to support the Regional Prospective Observational Research
Tuberculosis (RePORT) Consortium to produce the highest quality observational and
interventional research on tuberculosis (TB), TB-HIV, and TB-COVID-19. To accomplish this
goal, TB-RICC 3.0 will: i) collaborate with RePORT Country-Network Data Centers and
Biorepositories to ensure that common data elements (CDE) of the Common Protocol and
Specimen Tracking are accessible through the Global Data Template; ii) organize and/or
strengthen select sites to participate in diagnostic studies and clinical trials; and iii) support the
RePORT Country-Networks to ensure further development of TB diagnostic laboratories, TB-
RICC 3.0 specialized laboratories, and biorepositories. Aims of TB-RICC 3.0 are: Coordinating
Center Structure and Function: develop a Leadership Group and Executive Committee; assure
effective communication internally and externally; establish a Data Hub to provide seamless data
management from collection to analysis; establish Scientific Working Groups; a Scientific Review
Committee and an Administrative Core; facilitate grant submissions to potential funders and
partners. Data Harmonization: Develop a data hub to collaborate with country-level data centers
to facilitate multiregional data workflow using the REDCap Harmonist platform and other tools;
Research: catalyze TB, TB/HIV and TB/COVID-19 research within and across RePORT Country
Networks, and with external partners; prioritize study of TB close contacts to evaluate biomarkers
predictive of progression to TB across three “omics” platforms and three continents; Capacity
Building: develop modular remote courses for capacity building in the components of TB research;
Mentor early-stage investigator (ESI) development. TB-RICC 3.0 will deliver high-impact
innovative research to advance TB Science and TB Control

Terms: <Africa><Architecture><Area><Asia><Biological Markers><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Brazil><COVID-19><CV-19><China><Clinical><Clinical Research><Clinical Study><Clinical Trials><Cohort Studies><Collaborations><Collection><Common Data Element><Communication><Concurrent Studies><Coronavirus Infectious Disease 2019><Country><Data><Data Collection><Data Element><Development><Diagnostic><Diagnostics Research><Drugs><East Indies><Elements><Engineering / Architecture><Ensure><Epidemiology><Feedback><Foundations><Generations><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><Goals><Grant><HIV/Mtb><HIV/TB><HIV/mycobacterium tuberculosis><HIV/tuberculosis><Human><Immunology><India><Indonesia><International><Intervention Studies><Investigators><Korea><Laboratories><Leadership><Logistics><M tuberculosis infection><M. tb infection><M. tuberculosis infection><M. tuberculosis/HIV><M.tb infection><M.tuberculosis infection><MTB infection><Mainland China><Malay Archipelago><Medication><Mentors><Modern Man><Monitor><Mycobacterium tuberculosis (MTB) infection><Mycobacterium tuberculosis infection><Netherlands East Indies><Observation research><Observation study><Observational Study><Observational research><Performance><Pharmaceutical Preparations><Population><Proteomics><Protocol><Protocols documentation><Publishing><Quality Control><Research><Research Design><Research Methodology><Research Methods><Research Personnel><Research Specimen><Research Support><Researchers><Review Committee><Science><Site><South Africa><South America><Specimen><Structure><Study Type><TB diagnostics><TB infection><Technology><Translational Research><Translational Science><Treatment outcome><Tuberculosis><Vaccines><Validation><bio-markers><biobank><biologic marker><biomarker><biomarker evaluation><biorepository><class material><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><course material><curricular material><data centers><data harmonization><data hub><data management><data standardization><data standards><design><designing><developmental><disseminated TB><disseminated tuberculosis><drug/agent><electronic data><epidemiologic><epidemiological><falls><frontier><geographic site><harmonized data><infection due to Mycobacterium tuberculosis><innovate><innovation><innovative><insight><instructional materials><intervention research><interventional research><interventional study><interventions research><learning materials><marker evaluation><multiomics><multiple omics><nano-string><nanostring><new diagnostics><next generation diagnostics><novel diagnostics><panomics><predictive biomarkers><predictive marker><predictive molecular biomarker><programs><prospective><research and methods><response><sample collection><sharing hub><specimen collection><study design><tool><transcriptomics><translation research><translational investigation><tuberculosis diagnostics><tuberculosis infection><tuberculous spondyloarthropathy><validations><work group><working group>